Staar Surgical CoSTAA +6.09%83 5-Year Yield-on-Cost % is 0.00 as of Jul. 08, 2026. GuruFocus rates STAA with a GF Score™ of 83/100 and a GF Value™ of $31.73 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 327 Medical Devices & Instruments companies, Staar Surgical Co ranks worse than 305810.09% on this metric.
Staar Surgical Co's yield on cost for the quarter that ended in Mar. 2026 was 0.00.
The historical rank and industry rank for Staar Surgical Co's 5-Year Yield-on-Cost % or its related term are showing as below:
STAA's 5-Year Yield-on-Cost % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.31 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
Staar Surgical Co (NAS:STAA) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Staar Surgical Co 5-Year Yield-on-Cost % Related Terms
STAA vs BLFS, ATRC, KMTS: 5-Year Yield-on-Cost % Comparison
For the Medical Instruments & Supplies subindustry, Staar Surgical Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Staar Surgical Co 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Staar Surgical Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Staar Surgical Co's 5-Year Yield-on-Cost % falls into.
Staar Surgical Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Staar Surgical Co (STAA) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 08, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Staar Surgical Co and its competitors. According to the industry distribution chart, Staar Surgical Co ranks #999999 out of 327 companies in the Medical Devices & Instruments industry.
Is Staar Surgical Co's 5-Year Yield-on-Cost % too high?
Staar Surgical Co's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, Staar Surgical Co ranks #999999 out of 327 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Staar Surgical Co has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Staar Surgical Co's 5-Year Yield-on-Cost % compare to BLFS and ATRC?
According to the Medical Devices & Instruments industry distribution chart, Staar Surgical Co ranks #999999 out of 327 companies for 5-Year Yield-on-Cost %. This places Staar Surgical Co in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.31. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.31, based on 327 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Staar Surgical Co and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Staar Surgical Co's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Staar Surgical Co stock overvalued right now?
Based on GuruFocus' analysis, Staar Surgical Co (STAA) is currently considered Modestly Undervalued. The stock's GF Value™ is $31.73, compared to a current price of $28.15 — trading 11.3% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Staar Surgical Co's overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Staar Surgical Co (STAA), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Staar Surgical Co (STAA) Overvalued in 2026?
Based on GuruFocus' analysis, Staar Surgical Co stock appears to be undervalued.
The current stock price of $28.15 is trading 11.3% below its estimated GF Value™ of $31.73.
GuruFocus considers Staar Surgical Co to be Modestly Undervalued.
Key valuation signals for STAA:
5-Year Yield-on-Cost %: 0.00
GF Value™: $31.73 vs. price of $28.15 (11.3% below fair value)
No single metric tells the full story. See the STAA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.
83GF Score
Get the complete analysis for STAA
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STAA has been successfully added to your 